INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS - Sensus Healthcare (NASDAQ:SRTS)
NEW YORK, Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ( "Sensus" or the "Company" ) SRTS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
How this was made
The 30-second read
Why it matters
Legal scrutiny may temporarily depress stock price; long-term effects depend on investigation outcome.
Market read
The news is highly relevant to SRTS investors and healthcare sector observers, with potential short-term volatility.
What to watch
Potential positive developments or settlement could mitigate negative impact.
Background
Sensus Healthcare is under investigation following claims raised by Pomerantz LLP, which may relate to corporate governance or product issues.
Ticker impact
The news pertains directly to Sensus Healthcare, Inc. (SRTS), as it involves an investor investigation into the company.
Potential short-term decline of 5-10% due to increased uncertainty; long-term impact uncertain pending investigation outcome.
Legal investigations can cause short-term volatility; however, the actual impact depends on the investigation's findings and market perception.
Market effects
Potential negative sentiment in the healthcare and medical device sectors due to legal issues.
Limited to US markets, primarily affecting SRTS and related healthcare stocks.
Minimal; specific to US-based company and legal investigation.
Counterpoint
Legal investigations can sometimes be resolved favorably, leading to a quick rebound.
Key entities
- CompanySensus Healthcare, Inc.
A medical device company specializing in skin cancer treatment.
- Law FirmPomerantz LLP
Legal firm investigating claims on behalf of investors.
